State OK
Clinical Trials in Oklahoma
Recruiting clinical trials with at least one study location in Oklahoma. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oklahoma
Malignant Solid Neoplasm (6)Ovarian Cancer (5)Endometrial Cancer (5)Breast Cancer (4)Colorectal Cancer (4)Melanoma (3)Major Depressive Disorder (3)Anatomic Stage IV Breast Cancer AJCC v8 (3)Clinical Stage III Gastric Cancer AJCC v8 (3)Clinical Stage IV Gastric Cancer AJCC v8 (3)Lung Non-Small Cell Carcinoma (2)Sarcoma (2)
NCT02227251 Phase 2
Recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Ly...
Condition
Diffuse Large B-cell Lymphoma
Enrollment
244 pts
Location
United States, Australia, Austria
Sponsor
Karyopharm Therapeutics Inc
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.
NCT06821295 Phase 2, Phase 3
Recruiting
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencin...
Condition
Alcohol Misuse
Enrollment
600 pts
Location
United States
Sponsor
University of Oklahoma
NCT05600465 N/A
Recruiting
Behavioral Activation + Occupational Therapy: An Innovative Intervention for Emp...
Condition
Multiple Chronic Conditions
Enrollment
40 pts
Location
United States
Sponsor
University of Oklahoma
NCT05559671 Phase 4
Recruiting
Safety of the Herpes Zoster Subunit Vaccine in Lupus
Condition
Systemic Lupus Erythematosus
Enrollment
224 pts
Location
United States
Sponsor
NYU Langone Health
NCT06869512 N/A
Recruiting
Cooperative Extension and Cancer Survivorship
Condition
Cancer Survivorship
Enrollment
80 pts
Location
United States
Sponsor
University of Oklahoma
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06276491 Phase 1
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Condition
Ovarian Cancer
Enrollment
282 pts
Location
United States
Sponsor
Xencor, Inc.
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu...
Condition
Advanced Solid Tumors
Enrollment
365 pts
Location
United States, Canada, France
Sponsor
Marengo Therapeutics, Inc.
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disord...
Condition
Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT04858776 Phase 2
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thro...
Condition
Iliofemoral; Thrombosis
Enrollment
60 pts
Location
United States, Ireland, United Kingdom
Sponsor
Mercator MedSystems, Inc.
NCT06463340 Phase 1
Recruiting
Study of SGR-3515 In Participants With Advanced Solid Tumors.
Condition
Advanced Solid Tumor
Enrollment
52 pts
Location
United States, Canada
Sponsor
Schrödinger, Inc.
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP5...
Condition
Advanced Solid Tumor
Enrollment
300 pts
Location
United States, Australia, France
Sponsor
PMV Pharmaceuticals, Inc
NCT07226310 EARLY_Phase 1
Recruiting
The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study
Condition
Infertility
Enrollment
240 pts
Location
United States
Sponsor
University of Oklahoma
NCT01257269 N/A
Recruiting
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Pur...
Condition
Thrombotic Thrombocytopenic Purpura
Enrollment
450 pts
Location
United States, Austria, Czechia
Sponsor
Insel Gruppe AG, University Ho
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
NCT04485013 Phase 1
Recruiting
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Condition
Cancer
Enrollment
240 pts
Location
United States
Sponsor
Tizona Therapeutics, Inc
NCT06234423 Phase 1
Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer ...
Condition
Ovarian Cancer
Enrollment
263 pts
Location
United States, Australia
Sponsor
OnCusp Therapeutics, Inc.
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Condition
Colorectal Cancer
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT03747458 Phase 3
Recruiting
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Condition
Bilateral Nasal Polyposis
Enrollment
72 pts
Location
United States, Argentina
Sponsor
Optinose US Inc.
NCT03992378 N/A
Recruiting
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
Condition
Septic Shock
Enrollment
34 pts
Location
United States
Sponsor
University of Oklahoma
NCT07216482 Phase 3
Recruiting
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-03...
Condition
Hyperlipidemia
Enrollment
975 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT07221513 Phase 2
Recruiting
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and ...
Condition
HFrEF - Heart Failure With Reduced Ejection Fraction
Enrollment
30 pts
Location
United States
Sponsor
Salubris Biotherapeutics Inc
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group